LC16m8: An attenuated smallpox vaccine

The frequency of moderate to severe adverse reactions associated with smallpox vaccines currently stockpiled in the US, and the continued threat of bioterrorism have prompted the development of effective vaccines with improved safety profiles. LC16m8, an attenuated, replicating smallpox vaccine deri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenner, Julie, Cameron, Fiona, Empig, Cyril, Jobes, David V., Gurwith, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115618/
https://www.ncbi.nlm.nih.gov/pubmed/17052815
http://dx.doi.org/10.1016/j.vaccine.2006.03.087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115618/
https://www.ncbi.nlm.nih.gov/pubmed/17052815
http://dx.doi.org/10.1016/j.vaccine.2006.03.087

Ejemplares similares